Chongqing Claruvis Pharmaceutical Co., Ltd.
Clinical trials sponsored by Chongqing Claruvis Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot could loosen stiff arms after stroke Results expected Sep 2026 (estimated)
- New shot could ease stiff arms for stroke survivors Results expected Jun 2027 (estimated)
-
New shot could ease stiff arms for stroke survivors
Symptom relief Recruiting nowThis study tests a new injection (YY001) to relax tight arm muscles in adults who had a stroke. It aims to see if repeated treatments are safe and help with daily tasks like dressing and hygiene. About 300 people will take part over several months.
Phase 3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New shot could loosen stiff arms after stroke
Symptom relief Recruiting nowThis study tests a new injection called YY001 (a type of botulinum toxin) to reduce muscle stiffness in the arm or hand of adults who had a stroke. About 254 people will receive either the study drug or a placebo to see if it improves movement and daily tasks like dressing or hyg…
Phase 2/3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC